C&L: Picker tapped as new Tapestry president

Tapestry Pharmaceuticals has named Donald H. Picker, Ph.D. to the position of president, effective January 2, 2007. Dr. Picker joins Tapestry with more than 25 years of experience in all phases of oncology drug development.

XDx a molecular diagnostics company, has named Mitchell J. Nelles, PhD, to the position of vice president of research and development and technical operations.

Radius has appointed Nick Harvey to the position of senior vice president and CFO.

AviaraDx has named Carol Berry as vice president of sales.

Celgene Corporation has elected Sol J. Barer, Ph.D., CEO, to the additional position of chairman of the board.

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.